{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:48:44Z","timestamp":1786992524127,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jhlto.2025.100230","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T13:24:33Z","timestamp":1739885073000},"page":"100230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Impact of the angiotensin receptor-neprilysin inhibitor on chronic heart failure due to adult congenital heart disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"8","author":[{"given":"Bibhuti B.","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriprasad","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaros","family":"Nikolaidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhlto.2025.100230_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.106.627224","article-title":"Congenital heart disease in the general population","volume":"115","author":"Marelli","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100230_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCULATIONAHA.115.019307","article-title":"Congenital heart defects in the United States","volume":"134","author":"Gilboa","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100230_bib3","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1002\/ehf2.13378","article-title":"Heart failure related to adult congenital heart disease: prevalence, outcome and risk factors","volume":"8","author":"Arnaert","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100230_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000858","article-title":"Development of heart failure in young patients with congenital heart disease: a nationwide cohort study","volume":"6","author":"Gilljam","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.jhlto.2025.100230_bib5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/heartjnl-2020-318246","article-title":"Greater admissions, mortality and cost of heart failure in adults with congenital heart disease","volume":"107","author":"Burstein","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jhlto.2025.100230_bib6","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1002\/ehf2.13529","article-title":"Outcomes and healthcare resource utilization in adult congenital heart disease patients with heart failure","volume":"8","author":"Tsang","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100230_bib7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIR.0000000000000352","article-title":"Chronic heart failure in congenital heart disease","volume":"133","author":"Stout","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100230_bib8","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/heartjnl-2020-318787","article-title":"Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle","volume":"107","author":"Ladouceur","year":"2021","journal-title":"Heart."},{"key":"10.1016\/j.jhlto.2025.100230_bib9","first-page":"18","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100230_bib10","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhlto.2025.100230_bib11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jhlto.2025.100230_bib12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA."},{"key":"10.1016\/j.jhlto.2025.100230_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ahj.2017.12.021","article-title":"Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril\/Valsartan Therapy for Heart Failure (PROVE-HF)","volume":"199","author":"Januzzi","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jhlto.2025.100230_bib14","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Quality assessment scale: cohort studies. Ottawa Research Institute; 2012. Available at:\u00a0https:\/\/www.ohri.ca\/programs\/clinical_epedemiology\/oxford.asp."},{"key":"10.1016\/j.jhlto.2025.100230_bib15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jhlto.2025.100230_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/2150135119825599","article-title":"Early experience with sacubitril\/valsartan in adult patients with congenital heart disease","volume":"10","author":"Lluri","year":"2019","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"10.1016\/j.jhlto.2025.100230_bib17","first-page":"144","article-title":"Sacubitril\/valsartan for heart failure in adults with systemic right ventricle: a single center safety and efficacy experience","volume":"13","author":"Massardier","year":"2021","journal-title":"Arch Cardiovasc Dis Suppl"},{"key":"10.1016\/j.jhlto.2025.100230_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2019.06.031","article-title":"Sacubitril\/valsartan for heart failure in adults with complex congenital heart disease","volume":"300","author":"Maurer","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jhlto.2025.100230_bib19","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1016\/j.healun.2020.01.908","article-title":"Initial experience in adults with complex congenital heart disease treated with sacubitril\/valsartan for heart failure","volume":"39","author":"Goodwin","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2025.100230_bib20","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.cardfail.2020.09.293","article-title":"Tolerability and effect of angiotensin receptor neprilysin inhibitors in adult congenital patients with systemic right ventricle","volume":"26","author":"McCollum","year":"2020","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100230_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.hlc.2018.12.003","article-title":"Sacubitril\/valsartan in adult congenital heart disease patients with chronic heart failure - a single centre case series and call for an international registry","volume":"29","author":"Appadurai","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jhlto.2025.100230_bib22","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1136\/heartjnl-2020-318074","article-title":"Sacubitril\/valsartan in the treatment of systemic right ventricular failure","volume":"107","author":"Zandstra","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jhlto.2025.100230_bib23","article-title":"Sacubitril\/valsartan for heart failure in patients with complex adult congenital heart disease \u2013 experience from a tertiary center in Singapore","volume":"6","author":"Yan","year":"2021","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"10.1016\/j.jhlto.2025.100230_bib24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.hlc.2022.02.005","article-title":"Subjective and objective impact of angiotensin receptor-neprilysin inhibitors on systemic right ventricle patients","volume":"31","author":"Ephrem","year":"2022","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jhlto.2025.100230_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131152","article-title":"Clinical benefits of angiotensin receptor-neprilysin inhibitor in adults with congenital heart disease","volume":"387","author":"Andi","year":"2023","journal-title":"Int J Cardiol"},{"issue":"Suppl 8","key":"10.1016\/j.jhlto.2025.100230_bib26","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0735-1097(23)01989-7","article-title":"Long term outcomes with use of sacubitril\/valsartan in adults with congenital heart disease","volume":"81","author":"Gupta","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2025.100230_bib27","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/heartjnl-2022-322332","article-title":"Tolerability and beneficial effects of sacubitril\/valsartan on systemic right ventricular failure","volume":"109","author":"Nederend","year":"2023","journal-title":"Heart"},{"issue":"Suppl D","key":"10.1016\/j.jhlto.2025.100230_bib28","doi-asserted-by":"crossref","first-page":"D97","DOI":"10.1093\/eurheartjsupp\/suad111.226","article-title":"Use of sacubitril\/valsartan in a guch patient population. Preliminary study","volume":"25","author":"Sanfilippo","year":"2023","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jhlto.2025.100230_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009848","article-title":"Safety and efficacy of sacubitril\/valsartan in patients with a failing systemic right ventricle: a prospective single-center study","volume":"16","author":"Fusco","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100230_bib30","first-page":"e698","article-title":"AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American College Of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"2019","author":"Stout","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100230_bib31","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1017\/S1047951121003954","article-title":"Late outcome, therapy and systemic ventricular function in patients with a systemic right ventricle: data of the German National Register for Congenital Heart Defects","volume":"32","author":"Lebherz","year":"2022","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jhlto.2025.100230_bib32","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1409077","article-title":"Neprilysin inhibition for heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2025.100230_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008410","article-title":"Association between angiotensin receptor\u2013neprilysin inhibition, cardiovascular biomarkers, and cardiac remodeling in heart failure with reduced ejection fraction","volume":"14","author":"Murphy","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100230_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.892460","article-title":"Molecular mechanisms of sacubitril\/valsartan in cardiac remodeling","volume":"13","author":"Mustafa","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhlto.2025.100230_bib35","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1007\/s11010-023-04690-7","article-title":"Sacubitril\/valsartan reverses cardiac structure and function in experimental model of hypertension-induced hypertrophic cardiomyopathy","volume":"478","author":"Jeremic","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jhlto.2025.100230_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006617","article-title":"Angiotensin II receptor\u2013neprilysin inhibitor sacubitril\/valsartan improves endothelial dysfunction in spontaneously hypertensive rats","volume":"6","author":"Seki","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jhlto.2025.100230_bib37","doi-asserted-by":"crossref","first-page":"11472","DOI":"10.1038\/s41598-023-38694-6","article-title":"Sacubitril\/valsartan mitigates cardiac remodeling, systolic dysfunction, and preserves mitochondrial quality in a rat model of mitral regurgitation","volume":"13","author":"Tantisuwat","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhlto.2025.100230_bib38","doi-asserted-by":"crossref","first-page":"10081844","DOI":"10.3390\/biomedicines10081844","article-title":"Sacubitril\/valsartan and ivabradine attenuate left ventricular remodelmodelling and dysfunction in spontaneously hypertensive rats: different interactions with the renin\u2013angiotensin\u2013aldosterone system","volume":"10","author":"Simko","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jhlto.2025.100230_bib39","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0002-9149(00)01452-1","article-title":"Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure","volume":"87","author":"Hechter","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhlto.2025.100230_bib40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00246-002-0046-2","article-title":"Afterload reduction therapy in patients following intraatrial baffle operation for transposition of the great arteries","volume":"23","author":"Robinson","year":"2002","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jhlto.2025.100230_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2010.08.068","article-title":"Safety and efficiency of chronic ACE inhibition in symptomatic heart failure patients with a systemic right ventricle","volume":"154","author":"Tutarel","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jhlto.2025.100230_bib42","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0002-9149(01)02098-7","article-title":"Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries","volume":"88","author":"Lester","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhlto.2025.100230_bib43","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2025.100230_bib44","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/jcpt.13243","article-title":"Renal safety and efficacy of angiotensin receptor-neprilysin inhibitor: a meta-analysis of randomized controlled trials","volume":"45","author":"Feng","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jhlto.2025.100230_bib45","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/heartjnl-2018-314158","article-title":"Change in renal function associated with drug treatment in heart failure: national guidance","volume":"105","author":"Clark","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jhlto.2025.100230_bib46","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7861\/clinmed.2019-0422","article-title":"Heart failure and acute renal dysfunction in the cardiorenal syndrome","volume":"20","author":"Chahal","year":"2020","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.jhlto.2025.100230_bib47","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/eurheartj\/ehad890","article-title":"Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic right ventricular heart failure: the PARACYS-RV trial","volume":"45","author":"Chaix","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhlto.2025.100230_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12872-024-03833-y","volume":"24","author":"Freilinger","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jhlto.2025.100230_bib49","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1002\/ehf2.13574","article-title":"Study design and rationale of the pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA-R)","volume":"8","author":"Sinning","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100230_bib50","article-title":"The protocol and rationale for the efficacy aNd ToleRability of sacUbitril-valSarTan in adult congenital heart disease patients with heart failure (ENTRUST ACHD HF) registry","volume":"3","author":"Appadurai","year":"2021","journal-title":"Int Jl Cardiol Congenit Heart Dis"},{"key":"10.1016\/j.jhlto.2025.100230_bib51","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cardfail.2023.03.011","article-title":"Safety and treatment experience with sodium\/glucose cotransporter-2 inhibitors in adult patients with congenital heart disease","volume":"29","author":"Saef","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100230_bib52","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jchf.2024.01.006","article-title":"Dapagliflozin in patients with a failing systemic right ventricle: results from the DAPA-SERVE trial","volume":"12","author":"Fusco","year":"2024","journal-title":"JACC Heart Fail"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133425000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133425000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T18:17:40Z","timestamp":1747851460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133425000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":52,"alternative-id":["S2950133425000254"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2025.100230","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the angiotensin receptor-neprilysin inhibitor on chronic heart failure due to adult congenital heart disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2025.100230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100230"}}